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A VAMP7/Vti1a SNARE complex distinguishes a non-conventional trafﬁc
route to the cell surface used by KChIP1 and Kv4 potassium channels
Sarah E. FLOWERDEW and Robert D. BURGOYNE1
The Physiological Laboratory, School of Biomedical Sciences, University of Liverpool, Crown Street, Liverpool L69 3BX, U.K.
The KChIPs (K
+ channel-interacting proteins) are EF hand-
containing proteins required for the trafﬁc of channel-forming
Kv4 K
+ subunits to the plasma membrane. KChIP1 is targeted,
through N-terminal myristoylation, to intracellular vesicles that
appear to be trafﬁcking intermediates from the ER (endoplasmic
reticulum) to the Golgi but differ from those underlying conven-
tional ER–Golgi trafﬁc. To deﬁne KChIP1 vesicles and the
trafﬁc pathway followed by Kv4/KChIP1 trafﬁc, we examined
theirrelationshiptopotentialSNARE(solubleN-ethylmaleimide-
sensitive fusion protein-attachment protein receptor) proteins
mediating the trafﬁcking step. To distinguish Kv4/KChIP1 from
conventional constitutive trafﬁc, we compared it to the trafﬁc
oftheVSVG(vesicular-stomatitisvirusG-protein).Expressionof
KChIP with single or triple EF hand mutations quantitatively
inhibited Kv4/KChIP1 trafﬁc to the cell surface but had no
effect on VSVG trafﬁc. KChIP1-expressing vesicles co-localized
with the SNARE proteins Vti1a and VAMP7 (vesicle-associated
membrane protein 7), but not with the components of two
other ER–Golgi SNARE complexes. siRNA (small interfering
RNA)-mediated knockdown of Vti1a or VAMP7 inhibited Kv4/
KChIP1trafﬁc to the plasma membrane in HeLa and Neuro2A
cells. Vti1a and VAMP7 siRNA had no effect on VSVG trafﬁc or
thatofKv4.2whenstimulatedbyKChIP2,aKChIPwithdifferent
intrinsicmembranetargetingcomparedwithKChIP1.Thepresent
results suggest that a SNARE complex containing VAMP7 and
Vti1a deﬁnes a novel trafﬁc pathway to the cell surface in both
neuronal and non-neuronal cells.
Key words: calcium-binding protein, K
+ channel-interacting pro-
tein (KChIP), potassium channel, neuronal calcium sensor
(NCS) protein, soluble N-ethylmaleimide-sensitive fusion
proteinattachment protein receptor (SNARE).
INTRODUCTION
Kv4potassiumchannelswereﬁrstidentiﬁedashomologuesofthe
Drosophila Shal channels and are now known to have key roles in
theregulationoftheexcitabilityofneuronsandcardiacmyocytes.
In mammals, four members of the Kv4 family (Kv4.1, 4.2, 4.3
shortand4.3long)areknown[1]andtheyarehighlyexpressedin
the brain and heart [2]. Kv4 potassium channels are responsible
for the transient outward A-type current in neurons, and its
equivalent in myocytes. In the brain, it is thought that this current
is responsible for attenuating back-propagating action potentials
andexcitatorypost-synapticpotentials[3].Thechannelsalsolimit
action potentials to individual dendritic compartments [4] and
abnormalities in Kv4 channel function have been implicated in
the hyperexcitability underlying epilepsy [5].
When Kv4 channels are expressed alone in non-neuronal cells,
their properties differ from those seen with native channels [6].
A search for interacting partners that could reconstitute native
functions led to the discovery of the KChIPs (K
+ channel-inter-
acting proteins) [6], which are members of the NCS (neuronal
calcium sensor) family of proteins [7,8]. The KChIPs have four
EF-hand domains, of which three can potentially bind Ca
2+ and
two were seen to be occupied by Ca
2+ in the crystal structure
of KChIP1 [9,10]. Of the four KChIPs, only KChIP1 has an
N-terminal myristoyl group that is required for it to bind to
membranes [11] and, uniquely, allows its targeting to a distinct
population of intracellular 50–100 nm diameter vesicles (referred
from now onwards as KChIP1 vesicles) that partially overlap
with markers of the ERGIC [ER (endoplasmic reticulum)–Golgi
intermediate compartment] [12]. The KChIPs have two effects
on Kv4 channels. Firstly, the KChIPs modulate the properties of
the channel, particularly its inactivation kinetics [6]. Secondly,
they increase current density by promoting the trafﬁc of the Kv4
channel to the plasma membrane [6,12–15]. Kv4 proteins alone
are able to exit from the ER, but then become trapped in the Golgi
complex [11,12]. Co-expression of Kv4 channels with KChIPs
leads to their trafﬁc and co-localization at the plasma membrane
[11,12], where the KChIPs are constitutive channel subunits
[9,10].
The conventional exocytic pathway from the ER has been
studied in detail by following the trafﬁc of a temperature-sensit-
ive mutant of the VSVG (vesicular-stomatitis virus G-protein)
[16,17].TrafﬁcofVSVGfromtheERinvolvesbuddingofCOPII-
coated vesicles controlled by the GTPase Sar1 [18] and requires
Rab1 [19]. The vesicle then passes through the intermediate
compartment, the ERGIC [20] and through the Golgi complex
in a COPI-dependent manner before trafﬁcking to the plasma
membrane. There is growing evidence in the literature that this
single pathway is not responsible for all trafﬁc from the ER to
the Golgi. In yeast, there is evidence that both COPII- and COPI-
coated vesicles can bud from the ER [21]. Proteins bound to
the membrane via a GPI (glycosylphosphatidylinositol) anchor
are found in vesicles distinct from those carrying standard marker
proteins[22,23].Inmammaliancells,procollagenistoolargetoﬁt
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endoplasmic reticulum; ERGIC, ER–Golgi intermediate compartment; EYFP, enhanced yellow ﬂuorescent protein; FBS, foetal bovine serum; GAP, GTPase-
activating protein; GFP, green ﬂuorescent protein; KChIP, K+ channel-interacting protein; LAMP, lysosomal-associated protein; PCTV, pre-chylomicron
transport vesicle; siRNA, small interfering RNA; SNARE, soluble N-ethylmaleimide-sensitive fusion protein-attachment protein receptor; TBC1D20, TBC
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intothe60–80 nmdiameterCOPIIvesicles.Althoughprocollagen
appears to require COPII for exit from the ER, it is not found in
COPII-coated vesicles, and has no requirement for COPI [24,25].
Also, several proteins known to affect the transport of the marker
VSVG do not affect procollagen transport and vice versa [25]. In
the intestine, distinct triacylglycerol transport vesicles, PCTVs
(pre-chylomicron transport vesicles) can bud from the ER in
a COPII-independent manner, and are lacking in COPI, but need
COPII later in the pathway to fuse with the Golgi [26]. Rab1-
independent trafﬁc from the ER has been suggested to occur for
some cargos in non-neuronal [27] and neuronal cell types [28]. It
has been shown that the trafﬁc of Kv4 channels, with associated
KChIP1, also occurs by an alternate pathway that is COPII-
independent [12]. KChIP1 vesicles seem to be key intermediates
in ER to Golgi trafﬁc but the nature of this pathway and the
KChIP1 vesicles involved in trafﬁc are unknown.
Membrane trafﬁc steps can be deﬁned by the nature of
the SNARE (soluble N-ethylmaleimide-sensitive fusion protein-
attachment protein receptor) complex that underlies the fusion
of vesicles with their target membrane. SNAREs have been
deﬁned as Q or R SNAREs and, based on sequence classiﬁcation
of SNARE subfamilies, active complexes appear to have the
composition QaQbQcR [29]. Three such complexes have been
implicated in ER to Golgi trafﬁc. From analysis of VSVG trafﬁc,
the SNARE complex for the step between ER and the ERGIC
consists of Sec22b, membrin, rBet1 and syntaxin 5 [30,31]. The
complex of GOS28, Ykt6, rBet1 and syntaxin 5 is thought to be
involved in the fusion of intermediates with the cis-Golgi [32].
Finally, a third complex, comprising VAMP7 (vesicle-associated
membrane protein 7), Vti1a, rBet1 and syntaxin 5, has been
identiﬁed in the alternative ER to Golgi trafﬁcking pathway for
PCTVs in intestinal cells [4,33]. The general signiﬁcance of this
latter complex in cargo trafﬁc is unknown. We aimed to further
characterizethenatureoftheKChIP1vesiclesandthetrafﬁcroute
taken by Kv4/KChIP1. The results show that the KChIP1 vesicles
and Kv4/KChIP1 trafﬁc are distinguished by a VAMP7/Vti1a-
containing SNARE complex.
METHODS
Cell culture and transfection
HeLa human cervical carcinoma cells were grown in DMEM
(Dulbecco’s modiﬁed Eagle’s medium; Gibco) with 5%
FBS (foetal bovine serum; Gibco), 1% non-essential amino
acids (Gibco), and 1% penicillin-streptomycin (10000 units/ml
penicillin and 10000 μg/ml streptomycin; Gibco) and kept at
37◦Ci na5 % CO2 atmosphere. Neuro2A cells were cultured
in DMEM with 10% FBS and 1% penicillin/streptomycin.
For transfection, cells were grown in 24 well plates, with glass
coverslipsforimagingstudies.Cellswereplatedat∼4×10
5 cells
perwell,in1 mlsupplementedmedium,andincubatedfor5–24 h
before transfection. For the transfection reaction mixture, 3 μlo f
GeneJuice (Novagen) per μg of DNA was incubated for 5 min
at room temperature with OptiMEM serum-free media (Gibco)
to give a total reaction volume of 100 μl. Plasmid DNA (1 μg)
was then added and the mixture incubated for a further 15 min,
before being added drop-wise to the cells. Cells were then left for
24–72 h post-transfection.
Plasmids
Plasmids encoding KChIP1, KChIP1–EYFP (enhanced yellow
ﬂuorescent protein), KChIP1EF2–4–EYFP, KChIP1EF2–4–
dsRed, KChIP2–ECFP (enhanced cyan ﬂuorescent protein),
ARF1 (ADP-ribosylation factor 1)–EYFP and Kv4.2 have
beendescribedpreviously[11,12,34,35].TheKChIP1EF3–EYFP
plasmid bearing the mutations D135A and G140A was prepared
in this laboratory by Dr Burcu Hasdemir. The ts045 VSVG–GFP
(green ﬂuorescent protein) plasmid [17] was provided by John
Presley (National Institutes of Health, Bethesda, MD, U.S.A.).
The plasmid encoding the Rab1 GAP (GTPase-activating
protein) TBC1D20 [TBC (Tre-2/Bub2/Cdc16) domain family,
member 20] was a gift from Francis Barr (School of Cancer
Studies, University of Liverpool, U.K.). The EYFP–Golgi
plasmid encoding EYFP linked to the N-terminus of β1,4-
galactosyltransferase for trans- and medial-Golgi targeting was
obtained from Clontech (Mountain View, CA, U.S.A.).
Immunocytochemistry
After transfection, cells on coverslips were gently washed three
times in PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and
2m MN a H 2PO4, pH 7.4). Cells were then ﬁxed in PBS with 4%
formaldehyde for 30 min at room temperature (22◦C). Coverslips
for imaging were then washed again before being air dried, and
mountedasdescribedbelow.Forimmunoﬂuorescence,cellswere
washed in PBS after ﬁxation, then permeabilized in PBT [PBS
plus 0.1% (v/v) Triton X-100 and 0.3% (v/v) BSA] for 30 min.
Cells were then incubated with the primary antibody overnight
at 4 ◦C. Antibodies were diluted in PBS with 0.3% BSA. These
included mouse monoclonal antibodies to membrin, VAMP7 and
GOSR1 (GOS28), obtained from Abcam (Cambridge, U.K.) a
mouse monoclonal antibody to Sec22L1 (Sec22b) from Abnova
(Taipei, Taiwan) and a mouse monoclonal anti-Vti1a antibody
fromBDBiosciences(SanJose,CA,U.S.A.).Achickenanti-Ykt6
antibody was obtained from J. C. Hay (Division of Biological
Sciences, University of Montana, Missoula, MT, U.S.A.) [36].
A rabbit anti-TI-VAMP (VAMP7) antibody was a gift from
Thierry Galli (Institut Jacques Monod, Paris, France). Rabbit
polyclonal antibodies against syntaxin 7 or 8 were obtained
from Synaptic Systems (Goettingen, Germany). Anti-LAMP1
(lysosomal-associated protein 1) was a rabbit polyclonal obtained
from Afﬁnity Bioreagents (Golden, CO, U.S.A.). The primary
antibodywasremoved,cellswerewashedthreetimesinPBT,and
the secondary antibody was added for 1 h at room temperature.
Secondary antibodies were diluted in PBS with BSA, at 1:80
dilution for both anti-mouse and anti-rabbit IgG conjugated
to TRITC (tetramethylrhodamine β-isothiocyanate; Sigma, St.
Louis, MO, U.S.A.) or 1:250 for Alexa Fluor® 488 and Alexa
Fluor® 594-linkedsecondaryantibodiesobtainedfromMolecular
Probes/Invitrogen (Carlsbad, CA, U.S.A.). Cells were washed
again in PBT, and then dried, before mounting using ProLong
Gold Antifade (Invitrogen).
Confocal microscopy
Transfected cells were viewed using a Leica TCS-SP2-AOBS
confocalmicroscope(Leica,Germany),usinga66.86 μmpinhole
and a 63× water-immersion objective with a 1.2 numerical
aperture. For EYFP constructs, an excitation of 488 nm was
used, and an emission range of 500–540 nm was recorded. For
TRITC-tagged secondary antibody signals, a 543 nm laser was
used for excitation, and emission at 570–680 nm was recorded.
GFP was imaged using excitation at 488 nm and light collection
at 500–550 nm. ECFP was imaged using 405nm excitation and
light collections between 500–550 nm. HcRed was imaged by
excitation at 494 nm and light collected at 610–700 nm. Alexa
Fluor® 488 was excited at 488 nm, and emissions were recorded
from 500–550 nm. Alexa Fluor® 594 was excited at 594 nm, and
emissions were recorded from 605–670 nm.
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Figure 1 Effects of KChIP1 and KChIP1 with EF hand mutations on trafﬁc of Kv4.2 and VSVG to the plasma membrane
HeLa cells were transfected to co-express Kv4.2 and EYFP–Golgi (A–C) or ARF1–EYFP (D–F) or with wild-type KChIP1-EYFP (G), with the single EF hand mutant KChIP1EF3-EYFP (H)
or with the triple EF-hand mutant KCHIP1EF2–4-EYFP (I) and Kv4.2 localization was determined by using anti-Kv4.2 immunostaining. HeLa cells were transfected to express VSVG–GFP
alone (J), or with wild-type KChIP1 (K) or the triple EF-hand mutant KCHIP1EF2–4-HcRed (L) and VSVG–GFP localization was determined by confocal imaging. The scale bars
represent 10μm. Normalized trafﬁc of Kv4.2 (M) or VSVG–GFP (N) in the presence of various KChIPs was quantiﬁed and the results shown as means+ −S.E.M. from 20 cells for each
condition. w/t, wild-type.
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Figure 2 Inhibition of Rab1 function prevents trafﬁc of Kv4.2/KChIP1 to the plasma membrane
HeLacellswereco-transfectedtoexpressbothKChIP1–EYFPandKv4.2andimmunostainedwithanti-Kv4.2sothatlocalizationofKChIP1(A)andKv4.2(B)couldbevisualized.Alternatively,thecells
were additionally co-transfected to express the Rab1 GAP TBC1D20 (D–F). The colour overlays (C and F) show co-expressed proteins in green (KChIP1–EYFP) and red (Kv4.2), with co-localization
appearing in yellow. The scale bars represent 10μm. Normalized trafﬁc of Kv4.2 in the absence (cont) or presence (GAP) of TBC1D20 was quantiﬁed and the data shown as means+ −S.E.M. from
20 cells for each condition (G).
siRNA (small interfering RNA) knockdown
Expression of SNARE proteins was inhibited using siRNA
oligonucleotide duplexes. Three duplexes were obtained against
SYBL1, the gene for VAMP7 (Ambion, U.K., siRNA ID numbers
241467, 241468 and 241469) and three against Vti1a (Ambion,
U.K., siRNA ID numbers 37855, 37946 and 38033). A Silence
negativecontrolsiRNA#1(Ambion,AM4611)wasalsoobtained.
All siRNAs were resuspended in nuclease-free water, to give
a ﬁnal concentration of 100 nM when used for transfection.
Cells were transfected with untagged Kv4.2, with or without
KChIP1–EYFP and siRNA or VSVG–GFP and siRNA. After
72 h, the cells were ﬁxed and images were obtained of both
KChIP1–EYFP and VSVG–GFP or Kv4.2 detected by immuno-
ﬂuorescent staining using an anti-Kv4.2 antibody (Exalpha
Biologicals, Shirley, MA, U.S.A.) at 1:500 dilution followed
by a TRITC-tagged secondary antibody. Using the Leica LCD
Lite software (Leica), regions of interest were drawn around the
perimeterofthecellandwithinthecell,togivearegionofinterest
at the cell periphery, including the plasma membrane that was
1 μm wide. The edge of the cell could easily be identiﬁed based
on either background ﬂuorescence or that due to VSVG/KV4.2.
The total level of ﬂuorescence was recorded for each region for
both channels and the percentage of ﬂuorescence at the plasma
membrane was calculated. For Kv4.2 ﬂuorescence, the back-
ground level of ﬂuorescence at the cell periphery in the absence
of co-expression of KChIP1 (typically 10% of the total [12]) was
determined for each experiment and subtracted from values for
cells expressing KChIP1. The resulting values were then divided
by the mean from each experiment of the percentage of Kv4.2 at
t h ep l a s m am e m b r a n ei nt h ep r e s e n c eo fK C h I P 1 .T h e s ed a t aa r e
shownasthenormalizedvalueforKv4.2trafﬁc.ValuesforVSVG
were similarly normalized to the control values. All results are
expressed as means+ −S.E.M. and statistical analyses (Student’s
unpaired t test) were carried out.
Real-time PCR
After 72 h post-transfection, mRNA was extracted from HeLa
cells using TRIzol reagent (Invitrogen, Paisley, U.K.) according
to the manufacturer’s instructions. mRNA was resuspended
in 30 μl RNase-free water (Sigma, Gillingham, U.K.), and
stored at −80 ◦C. cDNA was produced using ImProm-II
reverse transcriptase (Promega) following the manufacturer’s
instructions, and using Oligo (dT)15 primers (Promega). The
reaction proceeded with 5 min annealing at 25◦C, 60 min at 42◦C
and15 minofheatinactivationat70 ◦C.Forreal-timePCR,cDNA
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Figure 3 Co-localization of KChIP1 with VAMP7 and Vti1a
HeLa cells were transfected to express KChIP1–EYFP or KChIP1EF2–4–EYFP as indicated, ﬁxed and immunostained with mouse monoclonal antibodies speciﬁc for membrin (A), GOS28 (B),
VAMP7 (C and E)o rV t i 1 a( D and F). The images show the localization of the KChIP1 and the indicated SNARE proteins and the colour overlays show KChIP1–EYFP in green and anti-SNARE
staining in red with co-localization appearing in yellow. The scale bars represent 10 μm in the main Figures and 2μm in the enlarged inserts.
was diluted into a total volume of 15 μl, 7.5 μl SYBR Green
PCR master mix (Applied Biosystems, Warrington, U.K.) was
used with 1 μl primer mix (50 mM each of forward and reverse
primers). Each primer and cDNA combination was repeated in
triplicate. Experiments were run on a BioRad iQ5 thermal cycler.
After checking each run had completed correctly, the threshold
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Figure 4 Lack of co-localization of KChIP1 with syntaxin 7 and 8 or VAMP7 with LAMP1
HeLa cells were transfected to express KChIP1–EYFP, ﬁxed and immunostained with mouse monoclonal antibodies speciﬁc for syntaxin 7 (A–C) or syntaxin 8 (D–F). The images show that KChIP1
punctae are distinct from those stained by anti-syntaxin 7 or 8. In cells immunostained with anti-VAMP 7 and anti-LAMP1 (G–I), there was little overlap of the stained punctae. The colour overlays
show KChIP1–EYFP or anti-VAMP7 in green and anti-syntaxin 7, 8 or anti-LAMP1 in red, with co-localization appearing in yellow. The scale bars represent 10μm in the main Figures and 2 μmi n
the enlarged inserts.
cycle (Ct) was recorded, and averaged for each primer and cDNA
set. The relative levels of mRNA for each primer and for each
cDNA were calculated by comparison to results with primers for
β-actin, using the 2
−  Ct method [37].
RESULTS
KChIP1 EF-hand mutants distinguish between Kv4/KChIP1 and
VSVG trafﬁc to the plasma membrane
When expressed alone in HeLa cells, Kv4.2 channels do not
effectively reach the plasma membrane and remain trapped
intracellularly [12]. The intracellular Kv4.2 was highly co-local-
ized with two Golgi complex markers EYFP–Golgi (Figures 1A–
1C) or ARF1–EYFP (Figures 1D–1F), indicating retention in
the Golgi complex. In comparison, co-expression with KChIP1
results in trafﬁc of Kv4.2 to the plasma membrane (Figure 1G),
where it co-localizes with KChIP1 [12]. Mutations of either a
single EF hand (EF hand 3 in KChIP1EF3) or all three potentially
functional EF hands (in KChIP1EF2–4) to disrupt co-ordination
ofdivalentionspreventedthestimulatoryeffectontrafﬁcofKv4.2
(Figures 1H and 1I) and instead Kv4.2 was found on punctate
intracellular structures that co-localized with the KChIPs (results
not shown) as seen previously for the triple mutant [12]. To
comparethistrafﬁcpathwaytotheconventionalpathwayfollowed
by VSVG, we examinedthe effect of theinhibitory triple EF hand
mutantontrafﬁcofVSVG–GFPtotheplasmamembrane.Neither
wild-type nor the mutant KChIP1 had any effect on the levels of
VSVG–GFP that reached the plasma membrane (Figures 1J–1L).
These conclusions were conﬁrmed by quantiﬁcation of the level
of trafﬁcking of proteins (Figures 1M and 1N) in assays in which
ﬂuorescence in peripheral regions of interest were determined
[12] and normalized in comparison with control cells to provide
a value for relative trafﬁc to the plasma membrane for each
experiment. The KChIP1 EF hand mutations appeared, therefore,
to speciﬁcally impair the trafﬁc of Kv4.2/KChIP1.
Kv4.2/KChIP1 trafﬁc requires Rab1
Trafﬁc of VSVG out of the ER requires the function of Rab1
[38]. It has been suggested, however, that some cargo trafﬁc can
be independent of Rab1 function [27,28]. We tested, therefore,
whether trafﬁc of Kv4.2/KChIP1 was Rab1-dependent. The ap-
proachusedwastoco-expresstheidentiﬁedRab1GAPTBC1D20
[38].SincethisconvertsRab1intotheinactiveGDP-loadedform,
it acts as an effective and speciﬁc inhibitor of Rab1 function.
As described previously [38], we found that co-expression of
TBC1D20 inhibited trafﬁc of VSVG–EGFP (results not shown)
and also effectively inhibited trafﬁc to the plasma membrane of
Kv4.2 which remained intracellular but still co-localized with
KChIP1 (Figure 2). These results indicate a common Rab1
requirement for the conventional and the KChIP1-dependent
trafﬁcking pathways.
KChIP1 vesicles co-localize with the SNARE proteins VAMP7 and
Vti1a
When KChIP1 is expressed alone in HeLa cells, it is present
on punctate vesicular structures. However, the identity of these
vesicles is unclear. The best overlap with other intracellular
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Figure 5 VAMP7 and Vti1a siRNA speciﬁcally inhibits trafﬁc of Kv4.2/KChIP1 to the plasma membrane in HeLa cells
(A) HeLa cells were co-transfected to express both KChIP1–EYFP and Kv4.2 and immunostained with anti-Kv4.2 so that localization of KChIP1 and Kv4.2 could be visualized. Control cells are
shown as well as cells co-transfected with VAMP7 or Vtila siRNA as indicated. The colour overlays show co-expressed proteins in green (KChIP1–EYFP) and red (Kv4.2) with co-localization
appearing in yellow. The scale bars represent 10μm. Normalized trafﬁc of Kv4.2 in control cells and cells co-transfected with Vti1a (B) or VAMP7 (C) siRNAs was quantiﬁed and the results shown
as means+ −S.E.M. from 20 (Vti1A) or 25 (VAMP7) cells for each condition. cont, control; RNAi, RNA interference.
markers, albeit partial, was seen with the ERGIC marker ERGIC-
53, and the KChIP1 vesicles were suggested to be intermediates
in ER to Golgi trafﬁcking [11,12]. To further characterize
these vesicles, we aimed to determine which SNARE proteins
were associated with them. HeLa cells expressing KChIP1–
EYFP were stained with antibodies recognizing SNAREs that
are present in only one of the three complexes implicated in
ER to Golgi trafﬁc. Membrin, a component of the SNARE
complex in the conventional VSVG trafﬁc pathway [31], did
not show any signiﬁcant co-localization with the KChIP1–EYFP-
labelled vesicles (Figure 3A). There was also no co-localization
of KChIP–EYFP with GOS28 (Figure 3B), a component of a
SNARE complex in ERGIC to cis-Golgi trafﬁc [32]. Similarly,
no co-localization was seen with KChIP1 for Sec22b or Ykt6
(results not shown). In contrast, VAMP7 and Vti1a, two SNAREs
implicated in trafﬁc of pre-chylomicron transport vesicles from
ERtoGolgi[33],showedextensiveco-localizationwithKChIP1-
vesicles (Figures 3C and 3D). Using a polyclonal antiserum
against VAMP7 [39], similar results were found (results not
shown). Furthermore, the EF hand mutants of KChIP1, which
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Figure 6 VAMP7 knockdown does not affect the morphology or distribution of KChIP1 vesicles
HeLa cells were transfected to express KChIP1–EYFP, ﬁxed and immunostained with anti-VAMP7 in the absence (A) or presence (B) of VAMP7 siRNA so that localization of KChIP1 and VAMP7
could be visualized. The colour overlays show co-expressed proteins in green (KChIP1–EYFP) and red (VAMP7) with co-localization appearing in yellow. The scale bars represent 10μm. (C) For
quantitative PCR, mRNA was prepared from HeLa cells transfected in the presence of silent or VAMP7 siRNA and relative mRNA levels determined using real-time PCR. RNAi, RNA interference.
also labelled punctate vesicular structures, were also co-localized
with VAMP7 and Vti1a as shown for the triple EF hand mutant
(Figures 3E and 3F).
S i n c eV A M P 7h a sa l s ob e e ns h o w nt ob ep a r to faS N A R E
complex with syntaxins 7 and 8 in late endocytic trafﬁc [40], we
examined possible co-localization of KChIP1 vesicles with these
proteins.Despitesomeoverlappinglocalizationintheperinuclear
region of the cells, puncta labelled by KChIP were clearly
distinct from those labelled by anti-syntaxin 7 (Figures 4A–4C)
or anti-syntaxin 8 (Figures 4D–4F). We also examined potential
overlap with lysosomes. Over-expressed VAMP7 has been found
associated with lysosomes [41], but we saw little overlap of
staining for endogenous VAMP7 with that for the lysosomal
marker LAMP1. The results indicate that the VAMP7-positive
KChIP vesicles are not of late endosomal/lysosomal origin.
Functional involvement of VAMP7 and Vti1a in trafﬁc
of Kv4.2/KChIP1
Theco-localizationdatasuggestedapotentialroleforVAMP7and
Vti1a in the unconventional trafﬁc route taken by Kv4.2/KChIP1.
Inordertotestthispossibility,weusedRNAsilencingtoexamine
the effect of knockdown of these SNAREs on Kv4.2/KChIP1
trafﬁc. Three distinct siRNAs were tested for both Vti1a and
VAMP7 and their effect on the localization of KChIP1–EYFP
and Kv4.2 was examined. Cells treated with the siRNAs were
comparedwithcellsintheabsenceofsiRNAandalsowithcellsin
thepresenceofasilentsiRNA.Incontrolcells,KChIP1andKv4.2
wereco-localizedandfoundattheplasmamembrane(Figure5A).
Treatment with Vti1a or VAMP7 siRNA blocked trafﬁc of Kv4.2
channels to the plasma membrane and KChIP1–EYFP was also
found to be intracellular (Figure 5A). The proportion of Kv4.2
present at the plasma membrane was determined and expressed
as a normalized value for plasma membrane trafﬁc. The silent
siRNA had no effect on the amount of Kv4.2 trafﬁc but all three
Vtila and all three VAMP7 siRNAs had a signiﬁcant inhibitory
effect (Figures 5B and 5C). Further studies concentrated on use
of the most inhibitory Vti1a or VAMP7 siRNA.
In order to determine whether siRNA treatment affected the
KChIP1 vesicles, staining for VAMP7 was carried out on cells
transfectedtoexpressKChIP1–EYFP.Asseenabove,VAMP7co-
localizedwithKChIP1incontrolcells(Figure6A).Incellstreated
with VAMP7 siRNA, the levels of VAMP7 protein appeared
to be signiﬁcantly reduced and the effectiveness of the siRNA
knockdown of VAMP7 was conﬁrmed by real-time PCR to
measure relative mRNA levels (Figure 6C). Despite the knock-
down, the KChIP1 vesicles did not show any obvious alterations
in distribution or morphology and still showed co-localization
with low levels of VAMP7 (Figure 6B).
To determine whether the ability of the Vti1a and VAMP7
siRNAs to inhibit Kv4.2 trafﬁc was speciﬁc, we tested the effect
of the selected siRNAs on VSVG trafﬁc to the plasma membrane.
The appearance of VSVG–GFP at the plasma membrane was
apparent in control cells and also in cells treated with control
siRNA or Vti1a and VAMP7 siRNAs (Figure 7A). Quantiﬁcation
ofVSVGattheplasmamembraneindicatedthatthesiRNAswere
without effect (Figure 7B). These ﬁndings support the conclusion
that Vti1a and VAMP7 are speciﬁcally involved in an alternative
trafﬁc pathway that is distinct from the conventional pathway
from the ER followed by VSVG.
KChIP1istheonlyoneofthefourKChIPsthatismyristoylated,
and the only one that targets to the pool of intracellular vesicles
[11,13,34]. KChIP2, in contrast, is palmitoylated and targets
to the plasma membrane when expressed alone [15,34]. This
raisedthepossibilitythatitsstimulationofKv4trafﬁcmayinvolve
interaction with the channel in a distinct cellular compartment
and via a distinct cellular mechanism to that used by KChIP1. To
test this possibility, the effect of Vti1a and VAMP7 siRNAs on
KChIP2-stimulated trafﬁc of Kv4.2 was examined. No effect of
the siRNAs was detected (Figures 7C and 7D), consistent with
distinct pathways being used by KChIP1 and KChIP2 and again
conﬁrming the lack of a general disruptive effect of the siRNAs
on cellular function.
The studies so far were all carried out in HeLa cells, in
which KChIPs and Kv4 channels are not normally expressed.
To test the validity of the ﬁndings in a neuronal background,
Neuro2A neuroblastoma cells were used. In this cell line, Kv4.2
expressed alone again remained intracellular and co-localized
with a Golgi complex marker (Figure 8A), and required co-
expression of a KChIP for effective trafﬁcking to the plasma
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Figure 7 VAMP7 and Vti1a siRNA do not inhibit trafﬁc of VSVG or Kv4.2/KChIP2 to the plasma membrane
HeLa cells were transfected to express VSVG–GFP and imaged. Control cells are shown as well as cells co-transfected with silent, VAMP7 or Vtila siRNA as indicated (A). Normalized trafﬁc of VSVG
in control cells (cont) and cells co-transfected with silent, Vti1a or VAMP7 siRNAs was quantiﬁed and the results are shown from 20 cells for each condition (B). HeLa cells were transfected to
express KChIP2 and Kv4.2 and immunostained with anti-Kv4.2 to allow imaging of Kv4.2 localization. Control cells are shown as well as cells co-transfected with silent, VAMP7 or Vtila siRNA as
indicated (C). Normalized trafﬁc of Kv4.2 in control cells and cells co-transfected with silent, Vti1a or VAMP7 siRNAs was quantiﬁed and the results shown as means+ −S.E.M. from 30 cells for each
condition (D). The scale bars represent 10μm. RNAi, RNA interference.
membrane as seen in HeLa cells. KChIP1 vesicles had a more
perinuclear distribution in Neuro2A cells compared with HeLa
cells, but showed co-localization with both Vti1a and VAMP7
(Figures 8B and 8C). Treatment of Neuro2A cells with Vti1a and
VAMP7 siRNAs speciﬁcally inhibited trafﬁc of Kv4.2 channels
to the plasma membrane and instead these remained, in part, in an
intracellularcompartment(Figures8Dand8E)suggestingthatthe
Kv4.2/KChIP1trafﬁcalsoinvolvesVti1aandVAMP7inneuronal
cells.
DISCUSSION
The results presented in the present study support a role for
a VAMP7/Vti1a-containing SNARE complex in a novel trafﬁc
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Figure 8 VAMP7 and Vti1a siRNA speciﬁcally inhibit trafﬁc of Kv4.2/KChIP1 to the plasma membrane in Neuro2A cells
(A)Neuro2Acellsweretransfectedtoco-expressKv4.2andEYFP–Golgi.(BandC)Neuro2acellsweretransfectedtoexpressKChIP1–EYFP,ﬁxedandimmunostainedwithanti-Vti1aoranti-VAMP7
as indicated. (D) Neuro2a cells were co-transfected to express both KChIP1-EYFP and Kv4.2 and immunostained with anti-Kv4.2 so that localization of KChIP1 and Kv4.2 could be visualized.
Control cells are shown as well as cells co-transfected with silent, VAMP7 or Vtila siRNA as indicated. (E) Normalized trafﬁc of Kv4.2 in control cells (cont) and cells co-transfected with siRNAs was
quantiﬁed and the results shown as means+ −S.E.M. from 20 cells for each condition. The scale bars represent 10 μm. RNAi, RNA interference.
pathway that is used by KChIP1 in its stimulation of Kv4 trafﬁc
to the plasma membrane, but not by the conventional pathway
followed by the VSVG protein. This pathway appears to exist in
both non-neuronal (HeLa) and neuronal-derived (Neuro2A) cell
lines. Where in the secretory pathway are the KChIP1 vesicles
placed? KChIP1 is associated with 50–100 nm vesicles, and
we have previously concluded that the KChIP1 vesicles are an
intermediate in ER to Golgi trafﬁc based on their partial co-
localization with ERGIC-53 and the ﬁnding that an expressed
N-terminalfragmentofKChIP1blockedKv4.2trafﬁcandbecame
fully co-localized with an enlarged ERGIC compartment [11].
They were not COPII-coated nor was COPII function crucial for
Kv4.2/KChIP1 trafﬁc, although COPI function was [12]. This
pathway is likely to be distinct from the other non-conventional
ER to Golgi route, such as the well studied route for procollagen,
as this is COPII-dependent and COPI-independent [25]. We
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now show that the VAMP-7-positive KChIP1 vesicles do not
overlap with endosomal or lysosomal markers, consistent with
the interpretation that they lie in the early exocytic pathway and
with previous results suggesting a role for VAMP/Vti1a in ER to
Golgi trafﬁc of PCTVs [33].
VAMP7, which is otherwise known as TI-VAMP [42], appears
to be involved in multiple SNARE complexes in various trafﬁc
steps in different cell types. It has been shown to be involved
in endosomal/lysosomal trafﬁc where it can function in at least
two distinct SNARE complexes [40,41,43]. Despite a focus on
VAMP7inendosomaltrafﬁc,VAMP7isalsoinvolvedintransport
of apical vesicles to the plasma membrane in epithelial cells
[39]. In addition, it is clear that many of the vesicular VAMP7
structures identiﬁed by immunoﬂuorescence do not overlap with
endosomal/lysosomal markers. In PC12 cells, VAMP7 overlaps
to only a low extent with endosomal and lysosomal markers, and
it was noted that in HeLa cells the endogenous VAMP7 does not
co-localize with the lysosomal protein LAMP1 [44]. We have
now conﬁrmed the latter observation in the present study. These
ﬁndingssuggestthatVAMP7mayassociatewithavarietyofother
SNARE partners to function in multiple membrane trafﬁc steps
which may in part be cell type-speciﬁc [42]. It is noteworthy and
potentiallyrelevanttothecurrentstudythat,inneurons,VAMP7is
involved in axonal and dendritic outgrowth [45] and is associated
with as yet unidentiﬁed vesicular structures present in axons and
dendrites [44]. In PC12 cells, the VAMP7-labelled vesicles seen
by immuno-EM [44] are very similar in size and morphology to
those labelled by KChIP1 in HeLa cells [12].
The speciﬁcity of siRNA on Kv4.2/KChIP1 trafﬁc and lack
of general disruption of the secretory pathway was demonstrated
by the lack of effect on VSVG trafﬁc to the plasma membrane.
In addition, Vti1a and VAMP7 siRNAs had no effect on Kv4.2
trafﬁc stimulated by KChIP2. This latter result is not surprising
given the differing intrinsic localization of KChIP2 compared
with KChIP1. Since KChIP2 effectively targets to the plasma
membrane due to its palmitoylation even in the absence of Kv4.2
[15,34], it would be unlikely to encounter Kv4.2 in the same
compartment as KChIP1, but may do so at the level of the Golgi
where Kv4.2 accumulates when expressed alone and where many
palmitoyltransferases are located [46]. Interestingly, KChIP2 is
expressed at the highest level in the heart [47] where it is the
major KChIP and is indispensable for normal Kv4 function [48]
and VAMP7 is apparently not expressed in the heart [49].
SNARE complexes suggested to mediate ER to Golgi trafﬁc all
contain syntaxin 5 and rBet1, but three distinct complexes have
been indentiﬁed based on the identity of the other two SNAREs.
KChIP1/Kv4.2trafﬁcappearstoinvolveVti1aandVAMP7based
on co-localization and functional siRNA data. Vti1a has been
showntointeractwithsyntaxin5[50],andbothVti1aandVAMP7
have been found to be quantitatively recovered in a SNARE
complex with syntaxin 5 and rBet1, which was implicated in
ER to Golgi trafﬁc of PCTVs [33]. Since these organelles are
expressed in a tissue-speciﬁc manner, it was possible that the
Vti1a/VAMP7-dependent ER to Golgi trafﬁc could have been an
enterocyte-speciﬁc process. The present results further highlight
the distinctive nature of Kv4.2/KChIP1 trafﬁc and now suggest
that Vti1a/VAMP7 deﬁne a non-conventional pathway that may
be used for the trafﬁc of a range of cargo proteins in neuronal and
non-neuronal cell types.
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